Xie et al. revealed that METTL3 also binds to YTHDF2, which induces the degradation of target tumour suppressor mRNAs, including Klf4 and Setd7, regulating the progression of bladder cancer (Xie et al., 2020). Here, METTL3 is linked to urinary bladder carcinoma.